Mark Hammer, a private investor fromMelville, N.Y., and members of his family told the Securitiesand Exchange Commission they have acquired a total of 375,200shares of Exovir Inc, or 12.9 pct of the total outstanding.    Hammer said his group has been accumulating Exovir stocksince Oct 28, 1985 for investment purposes and may buy moreshares or sell all or part of his current stake.    While he said he has no intention of seeking control of thecompany, Hammer said that because of his "extensive businessexperience" and his interest in Exovir stock, he may be"invited" to become a member of the company's board. Reuter&#3;